Wynnewood, PA, United States of America

Partha S Banerjee

This inventor holds 16 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 2 EPO patents, primarily in Bronchodilator Compositions. Top assignees: Dey, L.p., Jpmorgan Chase Bank, N.a., Dey Pharma, L.p.. Active years: 2003-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Partha S Banerjee. Retrieved from https://idiyas.com/inventor/partha-s-banerjee

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 16 

% Patents Active = 81.3



Average Co-Inventor Count = 2.8

ph-index = 7

Forward Citations = 138(Granted Patents)


Location History:

  • Davis, CA (US) (2003 - 2004)
  • San Ramon, CA (US) (2003 - 2004)
  • Plainsboro, NJ (US) (2011)
  • Wynnewood, PA (US) (2008 - 2017)
  • Wynnewood, CA (US) (2017)

Company Filing History:


Years Active: 2003-2017

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Bronchodilator
Beta-Agonist
Formoterol
Albuterol
Ipratropium
Chronic Obstructive Pulmonary Disease
Asthma
Inhalation Solution
Compositions
Methods
Pediatric
Therapeutics
16 patents (USPTO):Explore Patents

Title: Partha S Banerjee: Innovator in Bronchodilating Compositions

Introduction

Partha S Banerjee is a notable inventor based in Wynnewood, PA (US). He has made significant contributions to the field of bronchodilating compositions, holding a total of 16 patents. His work focuses on developing innovative methods and compositions for treating bronchoconstrictive disorders.

Latest Patents

Among his latest patents are two key innovations. The first is titled "Bronchodilating beta-agonist compositions and methods." This patent provides compositions intended for administration as a nebulized aerosol, which contain formoterol or a derivative thereof. The methods outlined aim for the treatment, prevention, or amelioration of symptoms associated with bronchoconstrictive disorders. The second patent, "Formoterol/steroid bronchodilating compositions and methods of use thereof," also focuses on nebulized aerosol compositions. This invention combines formoterol with a steroidal anti-inflammatory agent, further enhancing treatment options for bronchoconstrictive disorders.

Career Highlights

Throughout his career, Partha S Banerjee has worked with prominent companies, including Dey, L.P. and JPMorgan Chase Bank, N.A. His experience in these organizations has contributed to his expertise in developing innovative medical solutions.

Collaborations

Partha has collaborated with notable professionals in his field, including Imtiaz A Chaudry and Stephen Pham. These collaborations have likely enriched his research and development efforts.

Conclusion

Partha S Banerjee stands out as an influential inventor in the realm of bronchodilating compositions. His patents reflect a commitment to improving treatment options for individuals with bronchoconstrictive disorders. His contributions continue to impact the medical field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…